At Bay Area Lyme Foundation, our mission is to find reliable diagnostics and better treatments for Lyme disease. Our belief is that these solutions will come about through innovative research leveraging new technologies and multidisciplinary approaches. We are excited about the new projects that are currently being explored. Lyme disease has long been underfunded, and the time to invest is now.
LYME DISEASE BIOBANK
Portland, OR
Creation of a national Lyme disease biobank
INSTITUTE FOR SYSTEMS BIOLOGY
Seattle, WA
Advanced proteomics and data analysis for Lyme biomarker discovery
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
San Francisco, CA
Lyme diagnostics, including RNA sequencing and TickChip
STANFORD BIOADD LABORATORY
Stanford, CA
Combination therapy clinical trial
Lyme and Alzheimer’s correlations
CD47 and Borrelia burgdorferi
Synergistic effects of anti-borrelial compounds
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Stanford, CA
Sequencing of Lyme patient antibody responses
STANFORD WOODS INSTITUTE FOR THE ENVIRONMENT
Stanford, CA
Bay Area tick infection rate study
UNIVERSITY OF CALIFORNIA, DAVIS
Davis, CA
Post-Antibiotic Persistence of Borrelia burgdorferi
GORDON RESEARCH CONFERENCE
Ventura, CA
Research conference on biology of spirochetes
IBIS BIOSCIENCES
Carlsbad, CA
Effective Lyme disease diagnostic
NORTHERN ARIZONA UNIVERSITY
Flagstaff, AZ
Bay Area tick infection rate study
Tick testing
COLORADO STATE UNIVERSITY
Fort Collins, CO
Borrelia reservoir study
UNIVERSITY OF CALIFORNIA, IRVINE
Irvine, CA
Model mapping of genes which influence the body’s response to the Lyme bacteria
THE HUDSON VALLEY HEALING ARTS CENTER
Hyde Park, NY
Data mining solutions for Lyme disease
THE DEAN CENTER FOR TICK BORNE ILLNESS
Charlestown, MA
Lyme Innovation Hackathon
MASSACHUSETTS INSTITUTE OF TECHNOLOGY AND HARVARD UNIVERSITY
Cambridge, MA
Project description: Paper-Based Diagnostics for Early Lyme Disease
BROAD INSTITUTE, INC
Cambridge, MA
Clinical Genomics of Lyme Disease and Novel Causes of Lyme-Like Illness
UCSF SCHOOL OF MEDICINE
San Francisco, CA
Development and validation of combined pathogen and host response panels for diagnosis of Lyme and other tick-borne infections
MATTHEW S. CROUGHAN, PHD
Reno, Nevada
Accelerate the development and commercialization of simple cures for Lyme disease and other tick-borne infections
STANFORD UNIVERSITY
Stanford, CA
Immunotherapy Targeting CD47 in Lyme disease and Post Treatment Lyme Disease Syndrome
VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER
Richmond, VA
Antibody Profiling of the Lyme Disease Biobank
TEXAS A&M UNIVERSITY
College Station, TX
Tick-Borne Pathogens in California and Texas
LYMEDISEASE.ORG/MYLYMEDATA
San Ramon, CA
MyLymeData Patient Registry 2020
HARVARD UNIVERSITY
Cambridge, MA
Ultra-Sensitive Diagnosis of Tick-Borne Pathogens Using Target Capture and Next-Generation Sequencing
CALIFORNIA CENTER FOR FUNCTIONAL MEDICINE
Kensington, CA
Evaluation of Medicinal Herbs for Activity against Different Forms of B. burgdorferi
UNIVERSITY OF CALIFORNIA, DAVIS
Davis, CA
Prevalence and Knowledge of Tick-borne Disease Among Forest Management Workers and Outdoor Recreators in California
THE ROCKEFELLER UNIVERSITY
New York, NY
Nanobodies for the Development of Lyme Disease Diagnostic Tests
VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY (VIRGINIA TECH)
Blacksburg, VA
Monoclonal antibody to detect the release of an unusual glycopeptide as a biomarker of infection for acute Lyme disease
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Chapel Hill, NC
Structural Biology Essential to Preclinical Development of Novel Borrelia Targeting Therapeutic and Diagnostic Imaging Agents
STANFORD UNIVERSITY
Stanford, CA
A peptide conjugated biosensor for direct detection of active Borrelia spirochetes in Lyme disease
NORTH CAROLINA UNIVERSITY
Raleigh, NC
A novel perspective on mental illness in children: Investigation of the association
between Bartonella and Borrelia infection and pediatric Tourette’s disorder
using serology and a novel droplet digital PCR approach
STANFORD UNIVERSITY
Stanford, CA
A peptide conjugated biosensor for direct detection of active Borrelia spirochetes in Lyme disease
GENEVA FOUNDATION
San Antonio, TX
Extracorporeal Blood Disinfection for Treatment of Persistent Lyme and Co-Infections: an ex-vivo safety, feasibility and efficacy pilot study.
BOSTON CHILDREN’S HOSPITAL
Boston, MA
Pediatric biobank
TULANE UNIVERSITY
New Orleans, LA
Lyme pathogenesis
UNIVERSITY OF LOUISVILLE
Louisville, KY
Differential scanning calorimetry for Lyme diagnosis
HARVARD-MASS GENERAL HOSPITAL
Boston, MA
Clinical research conference on tick-borne illness
MASSACHUSETTS GENERAL HOSPITAL
Boston, MA
Development of an antigen detection test for Lyme
JOHNS HOPKINS UNIVERSITY
Baltimore, MD
SLICE (Study of Lyme Immunology and Clinical Events) clinical study expansion
NATIONAL INSTITUTE OF STANDARDS & TECHNOLOGY
Gaithersburg, MD
Workshop on Lyme disease
NORTH CAROLINA STATE UNIVERSITY
Raleigh, NC
Lyme pathogenesis
Antimicrobials to treat Borrelia burgdorferi
AGILE SCIENCES
Raleigh, NC
New treatment attacking Borrelia biofilms
BLOOD SYSTEMS RESEARCH INSTITUTE
San Francisco, CA
Precision medicine for Lyme disease
UNIVERSITY OF CALIFORNIA, DAVIS
Davis, CA
Research to characterize post-antibiotic persistence of attenuated Borrelia burgdorferi
LOUISIANA STATE UNIVERSITY
Baton Rouge, LA
Tick chemoattractant(s) for Borrelia burgdorferi
SPAULDING REHABILITATION HOSPITAL
Charlestown, MA
Lyme Innovation Hackathon
SAN FRANCISCO STATE UNIVERSITY
San Francisco, CA
Identifying the spatial distribution and host-association of virulent genotypes of Borrelia burgdorferi in the western United States
BRANDEIS UNIVERSITY
Waltham, MA
Outsmarting smart bugs: Blocking immune evasion by Lyme and other pathogens
JOHNS HOPKINS UNIVERSITY
Baltimore, MD
Evaluation of Botanical Medicines for Activity Against Different Forms of B. burgdorferi
TULANE UNIVERSITY
Covington, LA
Assessment of Fibroblast growth factor receptor (FGFR) antagonists as possible therapeutic supplements in Lyme neuroborreliosis
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
New York, NY
Resistance and resilience to Lyme disease: engaging positive outliers to elucidate protective mechanisms and novel therapeutic strategies
KYRONYX BIOSCIENCES
Wilton, CT
In vitro cell culture testing of a novel pharmaceutical against Lyme and bartonella, stage 1
CORNELL UNIVERSITY
Ithaca, NY
Development of Lyme Disease Antimicrobials
THE UNIVERSITY OF TEXAS AT SAN ANTONIO
San Antonio, Texas
Repurposing drugs to eliminate survival of Borrelia burgdorferi in infected hosts
TEXAS A&M UNIVERSITY
College Station, TX
A novel approach to diagnose Lyme disease
STANFORD UNIVERSITY
Stanford (Palo Alto), CA
Early Detection of Acute and Chronic Symptoms of Lyme Disease Using Wearable Devices
UNIVERSITY OF NEW HAVEN
New Haven, CT
Biofilm Disruption
CERES NANOSCIENCES, INC.
Manassas, VA
Lyme Borreliosis Nanotrap® Urine Test
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
San Francisco, CA
p66 Blockade as a Novel Therapeutic Strategy for the Treatment of Lyme Disease
STANFORD UNIVERSITY
Stanford, CA
Investigating Antigen-Specific B cell Responses in Lyme Disease to Gain Mechanistic Insights and Develop Next-Generation Therapeutics
DUKE UNIVERSITY SCHOOL OF MEDICINE
Durham, NC
Preclinical Development of Novel Borrelia Sp. Targeting Therapeutic and Diagnostic Imaging Agents
UNIVERSITY OF NORTHERN FLORIDA
Jacksonville, FL
Tickborne Pathogens in Rocky Mountain Wood Ticks (Dermacentor andersoni) in the Bitterroot Mountains of Western Montana
TUFTS UNIVERSITY
Medford, MA
Anti-lipid antibodies for the diagnosis of persistent Lyme disease
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Chapel Hill, NC
A novel perspective on mental illness in children: Investigation of the association between Bartonella and Borrelia infection and pediatric Tourette’s disorder using serology and a novel droplet digital PCR approach
TUFTS UNIVERSITY
Medford, MA
Anti-lipid antibodies for the diagnosis of persistent Lyme disease
Lyme Disease BioBank
Click here for more information about our Lyme Disease Biobank.